H. J. M. Groen
Department of Pulmonary Diseases
University Hospital
Groningen
Netherlands
Name/email consistency: high
- Continuously infused carboplatin used as radiosensitizer in locally unresectable non-small-cell lung cancer: a multicenter phase III study. Groen, H.J., van der Leest, A.H., Fokkema, E., Timmer, P.R., Nossent, G.D., Smit, W.J., Nabers, J., Hoekstra, H.J., Hermans, J., Otter, R., van Putten, J.W., de Vries, E.G., Mulder, N.H. Ann. Oncol. (2004)
- PNU-145156E, a novel angiogenesis inhibitor, in patients with solid tumors: a phase I and pharmacokinetic study. Groen, H.J., de Vries, E.G., Wynendaele, W., van der Graaf, W.T., Fokkema, E., Lechuga, M.J., Poggesi, I., Dirix, L.Y., van Oosterom, A.T. Clin. Cancer Res. (2001)
- Paclitaxel and carboplatin in the treatment of small-cell lung cancer patients resistant to cyclophosphamide, doxorubicin, and etoposide: a non-cross-resistant schedule. Groen, H.J., Fokkema, E., Biesma, B., Kwa, B., van Putten, J.W., Postmus, P.E., Smit, E.F. J. Clin. Oncol. (1999)
